Whitton M, Pinart M, Batchelor JM, Leonardi-Bee J, Gonzalez U, Jiyad Z, et al. (May 2016). "Evidence-based management of vitiligo: summary of a Cochrane systematic review". The British Journal of Dermatology. 174 (5): 962–69. doi:10.1111/bjd.14356. PMID26686510. S2CID38560830.
Picardi A, Pasquini P, Cattaruzza MS, Gaetano P, Melchi CF, Baliva G, et al. (2003). "Stressful life events, social support, attachment security and alexithymia in vitiligo. A case-control study". Psychotherapy and Psychosomatics. 72 (3): 150–58. doi:10.1159/000069731. PMID12707482. S2CID22105282.
Ongenae K, Van Geel N, Naeyaert JM (April 2003). "Evidence for an Autoimmune Pathogenesis of Vitiligo". Pigment Cell Research. 16 (2): 90–100. doi:10.1034/j.1600-0749.2003.00023.x. PMID12622785.
Gregersen PK (2007). "Modern genetics, ancient defenses, and potential therapies". The New England Journal of Medicine. 356 (12): 1263–66. doi:10.1056/NEJMe078017. PMID17377166.
Whitton ME, Ashcroft, DM, González, U (October 2008). "Therapeutic interventions for vitiligo". Journal of the American Academy of Dermatology. 59 (4): 713–17. doi:10.1016/j.jaad.2008.06.023. PMID18793940.
Scherschun L, Kim JJ, Lim HW (2001). "Narrow-band ultraviolet B is a useful and well-tolerated treatment for vitiligo". Journal of the American Academy of Dermatology. 44 (6): 999–1003. doi:10.1067/mjd.2001.114752. PMID11369913. S2CID17431219.
Bae JM, Hong BY, Lee JH, Lee JH, Kim GM (May 2016). "The efficacy of 308-nm excimer laser/light (EL) and topical agent combination therapy versus EL monotherapy for vitiligo: A systematic review and meta-analysis of randomized controlled trials (RCTs)". Journal of the American Academy of Dermatology. 74 (5): 907–15. doi:10.1016/j.jaad.2015.11.044. PMID26785803.
Chaturvedi SK, Singh G, Gupta N (October 2005). "Stigma experience in skin disorders: an Indian perspective". Dermatologic Clinics. 23 (4): 635–42. doi:10.1016/j.det.2005.05.007. PMID16112439.
Olsson MJ, Juhlin L (2002). "Long-term follow-up of leucoderma patients treated with transplants of autologous cultured melanocytes, ultrathin epidermal sheets and basal cell layer suspension". The British Journal of Dermatology. 147 (5): 893–904. doi:10.1046/j.1365-2133.2002.04837.x. PMID12410698. S2CID42396825.
Whitton M, Pinart M, Batchelor JM, Leonardi-Bee J, Gonzalez U, Jiyad Z, et al. (May 2016). "Evidence-based management of vitiligo: summary of a Cochrane systematic review". The British Journal of Dermatology. 174 (5): 962–69. doi:10.1111/bjd.14356. PMID26686510. S2CID38560830.
Huggins RH, Schwartz RA, Janniger CK (2005). "Vitiligo"(PDF). Acta Dermatovenerologica Alpina, Pannonica et Adriatica. 14 (4): 137–42, 144–45. PMID16435042. Archived(PDF) from the original on 10 December 2006.
Picardi A, Pasquini P, Cattaruzza MS, Gaetano P, Melchi CF, Baliva G, et al. (2003). "Stressful life events, social support, attachment security and alexithymia in vitiligo. A case-control study". Psychotherapy and Psychosomatics. 72 (3): 150–58. doi:10.1159/000069731. PMID12707482. S2CID22105282.
Ongenae K, Van Geel N, Naeyaert JM (April 2003). "Evidence for an Autoimmune Pathogenesis of Vitiligo". Pigment Cell Research. 16 (2): 90–100. doi:10.1034/j.1600-0749.2003.00023.x. PMID12622785.
Gregersen PK (2007). "Modern genetics, ancient defenses, and potential therapies". The New England Journal of Medicine. 356 (12): 1263–66. doi:10.1056/NEJMe078017. PMID17377166.
Whitton ME, Ashcroft, DM, González, U (October 2008). "Therapeutic interventions for vitiligo". Journal of the American Academy of Dermatology. 59 (4): 713–17. doi:10.1016/j.jaad.2008.06.023. PMID18793940.
Scherschun L, Kim JJ, Lim HW (2001). "Narrow-band ultraviolet B is a useful and well-tolerated treatment for vitiligo". Journal of the American Academy of Dermatology. 44 (6): 999–1003. doi:10.1067/mjd.2001.114752. PMID11369913. S2CID17431219.
Bae JM, Hong BY, Lee JH, Lee JH, Kim GM (May 2016). "The efficacy of 308-nm excimer laser/light (EL) and topical agent combination therapy versus EL monotherapy for vitiligo: A systematic review and meta-analysis of randomized controlled trials (RCTs)". Journal of the American Academy of Dermatology. 74 (5): 907–15. doi:10.1016/j.jaad.2015.11.044. PMID26785803.
Chaturvedi SK, Singh G, Gupta N (October 2005). "Stigma experience in skin disorders: an Indian perspective". Dermatologic Clinics. 23 (4): 635–42. doi:10.1016/j.det.2005.05.007. PMID16112439.
Fabrikant J, et al. (July 2013). "A review and update on melanocyte stimulating hormone therapy: afamelanotide". J Drugs Dermatol. 12 (7): 775–79. PMID23884489.
Olsson MJ, Juhlin L (2002). "Long-term follow-up of leucoderma patients treated with transplants of autologous cultured melanocytes, ultrathin epidermal sheets and basal cell layer suspension". The British Journal of Dermatology. 147 (5): 893–904. doi:10.1046/j.1365-2133.2002.04837.x. PMID12410698. S2CID42396825.
"Questions and Answers about Vitiligo". National Institute of Arthritis and Musculoskeletal and Skin Diseases. 30 October 2016. Archived from the original on 8 August 2007. Retrieved 22 July 2018.
Whitton M, Pinart M, Batchelor JM, Leonardi-Bee J, Gonzalez U, Jiyad Z, et al. (May 2016). "Evidence-based management of vitiligo: summary of a Cochrane systematic review". The British Journal of Dermatology. 174 (5): 962–69. doi:10.1111/bjd.14356. PMID26686510. S2CID38560830.
Picardi A, Pasquini P, Cattaruzza MS, Gaetano P, Melchi CF, Baliva G, et al. (2003). "Stressful life events, social support, attachment security and alexithymia in vitiligo. A case-control study". Psychotherapy and Psychosomatics. 72 (3): 150–58. doi:10.1159/000069731. PMID12707482. S2CID22105282.
Scherschun L, Kim JJ, Lim HW (2001). "Narrow-band ultraviolet B is a useful and well-tolerated treatment for vitiligo". Journal of the American Academy of Dermatology. 44 (6): 999–1003. doi:10.1067/mjd.2001.114752. PMID11369913. S2CID17431219.
Olsson MJ, Juhlin L (2002). "Long-term follow-up of leucoderma patients treated with transplants of autologous cultured melanocytes, ultrathin epidermal sheets and basal cell layer suspension". The British Journal of Dermatology. 147 (5): 893–904. doi:10.1046/j.1365-2133.2002.04837.x. PMID12410698. S2CID42396825.
Huggins RH, Schwartz RA, Janniger CK (2005). "Vitiligo"(PDF). Acta Dermatovenerologica Alpina, Pannonica et Adriatica. 14 (4): 137–42, 144–45. PMID16435042. Archived(PDF) from the original on 10 December 2006.
Huggins RH, Schwartz RA, Janniger CK (2005). "Vitiligo"(PDF). Acta Dermatovenerologica Alpina, Pannonica et Adriatica. 14 (4): 137–42, 144–45. PMID16435042. Archived(PDF) from the original on 10 December 2006.
"Questions and Answers about Vitiligo". National Institute of Arthritis and Musculoskeletal and Skin Diseases. 30 October 2016. Archived from the original on 8 August 2007. Retrieved 22 July 2018.
Staff MC (15 May 2014). "Vitiligo Causes". Mayoclinic. Archived from the original on 30 April 2015. Retrieved 22 April 2015.